Allan NP, Raines AM, Capron DW, Norr AM, Zvolensky MJ, Schmidt NB. Identification of anxiety sensitivity classes and clinical cut-scores in a sample of adult smokers: results from a factor mixture model. J Anxiety Disord. 2014;28(7):696–703.

Article  PubMed  PubMed Central  Google Scholar 

American Psychiatric Association A. Diagnostic and statistical manual of mental disorders: DSM-5™. 5th ed. Washington: American Psychiatric Publishing, a division of American Psychiatric Association; 2013.

Book  Google Scholar 

Anderson JR, Killian M, Fuller A, Hughes JL, Byerly M, Lindow J, et al. Psychometric evaluation of the pediatric quality of life enjoyment and satisfaction questionnaire in a general youth population. Child Psychiatry Hum Dev. 2022;53(3):546–53.

Article  PubMed  Google Scholar 

Arranz MJ, Salazar J, Bote V, Artigas-Baleri A, Serra LA, Trivino E, et al. Pharmacogenetic interventions improve the clinical outcome of treatment-resistant autistic spectrum disorder sufferers. Pharmaceutics. 2022;14(5):999.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Biswas M, Vanwong N, Sukasem C. Pharmacogenomics and non-genetic factors affecting drug response in autism spectrum disorder in Thai and other populations: current evidence and future implications. Front Pharmacol. 2023;14:1285967.

Article  CAS  PubMed  Google Scholar 

Bose-Brill S, Xing J, Barnette DJ, Hanks C. Pharmacogenomic testing: aiding in the management of psychotropic therapy for adolescents with autism spectrum disorders. Pharmgenomics Pers Med. 2017;10:247–52.

CAS  PubMed  PubMed Central  Google Scholar 

Bousman CA, Stevenson JM, Ramsey LB, Sangkuhl K, Hicks JK, Strawn JR, et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A genotypes and serotonin reuptake inhibitor antidepressants. Clin Pharmacol Ther. 2023;114(1):51–68.

Article  CAS  PubMed  Google Scholar 

Bowers K, Lin PI, Erickson C. Pharmacogenomic medicine in autism: challenges and opportunities. Paediatr Drugs. 2015;17(2):115–24.

Article  PubMed  Google Scholar 

Cecchin E, Stocco G. Pharmacogenomics and personalized medicine. Genes (Basel). 2020;11(6):679.

Article  CAS  PubMed  Google Scholar 

Cheng AL, Downs DL, Brady BK, Hong BA, Park P, Prather H, et al. Interpretation of PROMIS depression and anxiety measures compared with DSM-5 diagnostic criteria in musculoskeletal patients. JBJS Open Access. 2023. https://doi.org/10.2106/JBJS.OA.22.00110.

Article  PubMed  PubMed Central  Google Scholar 

Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Focus (Am Psychiatr Publ). 2018;16(4):420–9.

PubMed  PubMed Central  Google Scholar 

Conelea CA, Schmidt ER, Leonard RC, Riemann BC, Cahill S. The Children’s Yale-Brown Obsessive Compulsive Scale: Clinician versus self-report format in adolescents in a residential treatment facility. J Obsess Compulsive Relat Disord. 2012;1(2):69–72.

Article  Google Scholar 

Elliott LS, Henderson JC, Neradilek MB, Moyer NA, Ashcraft KC, Thirumaran RK. Clinical impact of pharmacogenetic profiling with a clinical decision support tool in polypharmacy home health patients: a prospective pilot randomized controlled trial. PLoS ONE. 2017;12(2): e0170905.

Article  PubMed  PubMed Central  Google Scholar 

Endicott J, Nee J, Harrison W, Blumenthal R. Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacol Bull. 1993;29(2):321–6.

CAS  PubMed  Google Scholar 

Espadas C, Ballester P, Londono AC, Almenara S, Aguilar V, Belda C, et al. Multimorbidity and psychotropic polypharmacy among participants with autism spectrum disorder with intellectual disability. Psychiatry Res. 2020;292: 113321.

Article  CAS  PubMed  Google Scholar 

Ghanbarian S, Wong GWK, Bunka M, Edwards L, Cressman S, Conte T, et al. Cost-effectiveness of pharmacogenomic-guided treatment for major depression. CMAJ. 2023;195(44):E1499–508.

Article  PubMed  PubMed Central  Google Scholar 

Goodson R, Wagner J, Sandritter T, Staggs VS, Soden S, Nadler C. Pharmacogenetic testing in patients with autism spectrum disorder evaluated in a precision medicine clinic. J Dev Behav Pediatr. 2023;44(8):e505–10.

PubMed  PubMed Central  Google Scholar 

Greden JF, Parikh SV, Rothschild AJ, Thase ME, Dunlop BW, DeBattista C, et al. Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: a large, patient- and rater-blinded, randomized, controlled study. J Psychiatr Res. 2019;111:59–67.

Article  PubMed  Google Scholar 

Groessl EJ, Tally SR, Hillery N, Maciel A, Garces JA. Cost-effectiveness of a pharmacogenetic test to guide treatment for major depressive disorder. J Manag Care Spec Pharm. 2018;24(8):726–34.

PubMed  Google Scholar 

Health Quality O. Pharmacogenomic testing for psychotropic medication selection: a systematic review of the assurex genesight psychotropic test. Ont Health Technol Assess Ser. 2017;17(4):1–39.

Google Scholar 

Hicks JK, Bishop JR, Sangkuhl K, Muller DJ, Ji Y, Leckband SG, et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 genotypes and dosing of selective serotonin reuptake inhibitors. Clin Pharmacol Ther. 2015;98(2):127–34.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ho D, Imai K, King G, Stuart EA. MatchIt: nonparametric preprocessing for parametric causal inference. J Stat Softw. 2011;42(8):1–28.

Article  Google Scholar 

Hollocks MJ, Lerh JW, Magiati I, Meiser-Stedman R, Brugha TS. Anxiety and depression in adults with autism spectrum disorder: a systematic review and meta-analysis. Psychol Med. 2019;49(4):559–72.

Article  PubMed  Google Scholar 

Jukic MM, Haslemo T, Molden E, Ingelman-Sundberg M. Impact of CYP2C19 genotype on escitalopram exposure and therapeutic failure: a retrospective study based on 2,087 patients. Am J Psychiatry. 2018;175(5):463–70.

Article  PubMed  Google Scholar 

Kanu AA, Johnston MM, Poweleit EA, Vaughn SE, Strawn JR, Ramsey LB. Influence of CYP2D6 metabolizer status on risperidone and paliperidone tolerability in children and adolescents. J Child Adolesc Psychopharmacol. 2024;34(1):34–41.

Article  CAS  PubMed  Google Scholar 

Khan A, Fahl Mar K, Faucett J, Khan Schilling S, Brown WA. Has the rising placebo response impacted antidepressant clinical trial outcome? Data from the US Food and Drug Administration 1987–2013. World Psychiatry. 2017;16(2):181–92.

Article  PubMed  PubMed Central  Google Scholar 

Lai MC, Kassee C, Besney R, Bonato S, Hull L, Mandy W, et al. Prevalence of co-occurring mental health diagnoses in the autism population: a systematic review and meta-analysis. Lancet Psychiatry. 2019;6(10):819–29.

Article  PubMed  Google Scholar 

Lu J, Yang Y, Lu J, Wang Z, He Y, Yan Y, et al. Effect of CYP2D6 polymorphisms on plasma concentration and therapeutic effect of risperidone. BMC Psychiatry. 2021;21(1):70.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Masia-Warner C, Storch EA, Pincus DB, Klein RG, Heimberg RG, Liebowitz MR. The Liebowitz social anxiety scale for children and adolescents: an initial psychometric investigation. J Am Acad Child Adolesc Psychiatry. 2003;42(9):1076–84.

Article  PubMed  Google Scholar 

McCarthy JM, Chaplin E. Adults with intellectual disability and autism spectrum disorder: what is the evidence around the use of polypharmacy. Int J Environ Res Public Health. 2022;19(23):15974.

Article  PubMed  PubMed Central  Google Scholar 

Palumbo S, Mariotti V, Pellegrini S. A narrative review on pharmacogenomics in psychiatry: scientific definitions, principles, and practical resources. J Clin Psychopharmacol. 2024;44(1):49–56.

Article  PubMed  Google Scholar 

Patel JN, Mueller MK, Guffey WJ, Stegman J. Drug prescribing and outcomes after pharmacogenomic testing in a developmental and behavioral health pediatric clinic. J Dev Behav Pediatr. 2020;41(1):65–70.

Article  PubMed  Google Scholar 

Pestle S, Chorpita B, Schiffman J. Psychometric properties of the Penn State Worry Questionnaire for children in a large clinical sample. J Clin Child Adolesc Psychol. 2008;53(37):465–71.

Article